+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluticasone Propionate "

Cough Hypersensitivity Syndrome Market Report 2025 - Product Thumbnail Image

Cough Hypersensitivity Syndrome Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Sinusitis Pipeline Insight Analysis Report - Product Thumbnail Image

Sinusitis Pipeline Insight Analysis Report

  • Drug Pipelines
  • August 2024
  • 150 Pages
  • Global
From
From
From
COPD in the United States: Understanding the COPD Patient Experience - Product Thumbnail Image

COPD in the United States: Understanding the COPD Patient Experience

  • Report
  • January 2024
  • 156 Pages
  • United States
  • 8 Results (Page 1 of 1)
Loading Indicator

Fluticasone Propionate is a corticosteroid used to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is used to reduce inflammation in the airways, which helps to reduce symptoms such as wheezing, coughing, and shortness of breath. It is available in both inhaler and nasal spray forms, and is often prescribed in combination with other medications. Fluticasone Propionate is a widely used medication in the respiratory drug market, and is often prescribed as a first-line treatment for asthma and COPD. The Fluticasone Propionate market is highly competitive, with many pharmaceutical companies offering their own branded versions of the drug. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. Other companies such as Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals also offer generic versions of the drug. Show Less Read more